|
Market Closed -
Canadian Securities Exchange
09:36:50 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 2.250 CAD | -10.00% |
|
-10.00% | -43.75% |
| 09-08 | Me Therapeutics Holdings Advances in Vivo Car and Therapeutic Mrna Sting Programs | CI |
| 07-17 | ME Therapeutics Holdings Inc. announced that it has received CAD 0.576501 million in funding | CI |
Company Valuation: ME Therapeutics Holdings Inc.
Data adjusted to current consolidation scope
| Fiscal Period: August | 2024 | 2025 |
|---|---|---|
| Market Cap 1 | 69.27 | 118.4 |
| Change | - | 70.86% |
| Enterprise Value (EV) 1 | 67.77 | 117 |
| Change | - | 72.67% |
| P/E | -51.7x | -93.2x |
| PBR | 46.9x | 78.7x |
| PEG | 0.6x | 4.8x |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | -49.4x | -94.1x |
| EV / EBIT | -49.4x | -91.7x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -0.0531 | -0.0429 |
| Distribution rate | - | - |
| Net sales | - | - |
| EBITDA 1 | -1.373 | -1.244 |
| EBIT 1 | -1.373 | -1.276 |
| Net income 1 | -1.295 | -1.193 |
| Net Debt 1 | -1.497 | -1.331 |
| Reference price 2 | 2.750 | 4.000 |
| Nbr of stocks (in thousands) | 25,189 | 29,589 |
| Announcement Date | 11/27/24 | 11/27/25 |
1CAD in Million2CAD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 49.29M | |
| 31.04x | 5.6x | 16.76x | 1.05% | 45.48B | |
| -20.85x | 240.83x | -22.36x | -.--% | 43.68B | |
| 33.71x | 3.27x | 14.1x | -.--% | 43.09B | |
| 45.39x | 5.23x | 28.64x | -.--% | 39.4B | |
| 27.03x | 8.15x | 20.66x | 0.42% | 31.91B | |
| 33.41x | 5.47x | 24.85x | -.--% | 16.4B | |
| 23.57x | 2.06x | 8.94x | 1.13% | 14.24B | |
| 74.44x | 3.94x | 15.27x | -.--% | 13.28B | |
| Average | 30.97x | 34.32x | 13.36x | 0.33% | 27.5B | |
| Weighted average by Cap. | 26.17x | 46.68x | 11.79x | 0.31% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- METX Stock
- Valuation ME Therapeutics Holdings Inc.
Select your edition
All financial news and data tailored to specific country editions
